Histopathological Study of Hydroalcoholic Extract of Terminalia catappa Leaves in Treatment of Indomethacin-Induced Gastric Ulcer in Rats


Ardeshir Arzi 1 , Neda Sistani Karampour 2 , * , Anahita Rezaei 3 , Amin Gholamhoseyni 2

1 Department of Pharmacology and Toxicology, Faculty of Pharmacy, Physiology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

2 Department of Pharmacology, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran

3 Department of Pathobiology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran

How to Cite: Arzi A, Sistani Karampour N, Rezaei A, Gholamhoseyni A. Histopathological Study of Hydroalcoholic Extract of Terminalia catappa Leaves in Treatment of Indomethacin-Induced Gastric Ulcer in Rats, Jundishapur J Nat Pharm Prod. 2017 ; 12(3 (Supp)):e38019. doi: 10.5812/jjnpp.38019.


Jundishapur Journal of Natural Pharmaceutical Products: 12 (3 (Supp)); e38019
Published Online: September 4, 2016
Article Type: Research Article
Received: May 18, 2016
Revised: June 16, 2016
Accepted: June 22, 2016




Background: Traditional medicine discussed in the literature introduced Terminalia catappa (TC) L. as an antiulcer plant.

Objectives: In this study, we investigated the activity of hydroalcoholic extract from TC leaves against indomethacin-induced gastric ulcers in rats.

Methods: Animals were divided into 13 groups, each consisting of six rats. The rats fasted for 48 hours. Various doses of Terminalia catappa leaf extract (TCLE) (100, 200, 400, and 600 mg/kg), ranitidine (50 mg/kg), and normal saline (5 mL/kg) were administered orally to the assigned group of rats. Indomethacin (30 mg/kg) was administered to all six groups before treatment. Other groups received only TCLE (100, 200, 400, and 600 mg/kg), ranitidine (50 mg/kg), CMC (1% solution), or indomethacin. Five hours after the drugs were administered, the animals’ stomachs were opened through the large curvature and lesions were observed. One-way ANOVA and LSD tests were used for data analysis, and the minimum significance level was P < 0.05.

Results: The results showed that all doses of TCLE and ranitidine had a significant effect (P > 0.05) against the gastric damage caused by indomethacin. There was no significant difference (P > 0.05) between TCLE (400 mg/kg) and ranitidine.

Conclusions: The flavonoids, saponins, tannins, alkaloids, and antioxidant properties of TCLE can decrease some of the effects of an indomethacin-induced gastric ulcer.


Peptic Ulcer Indomethacin Rat Terminalia catappa

Copyright © 2016, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

1. Background

Peptic ulcer disease (PUD) affects a considerable number of people worldwide. It progresses when there is a disparity between the aggressive and protective factors at the luminal surface of the epithelial cells of the stomach. Aggressive factors include Helicobacter pylori, hydrochloric acid (HCl) secretions, pepsin, nonsteroidal anti-inflammatory drugs (NSAIDs), bile acids, ischemia, hypoxia, smoking, and alcohol. Defensive factors include bicarbonate, mucus layer protection, mucosal blood flow, prostaglandins, and growth factors (1).

Non-selective NSAIDs, including indomethacin, inhibit the cyclooxygenase1 (COX-1), which leads to the blocking of the gastric mucus secretion. In addition, the inhibition blocks the platelet production of thromboxane (TXA), which causes increased bleeding during active gastric bleeding (2).

Helicobacter pylori infections alone are the major causative factor of duodenal ulcers (95%) and gastric ulcers (80%). Sometimes lifestyle factors, such as smoking, alcohol, eating spicy foods, and stress, are also associated with peptic ulcer formation (3).

Although many products are used for the treatment of gastric ulcers, including antacids and antihistamines, most of these drugs, produce adverse reactions, such as arrhythmias, impotence, gynecomastia, and hematopoietic changes. Extracts of herbal plants have produced promising results in the treatment of gastric ulcers (4).

Terminalia catappa (TC) is a species of the family Combretaceae. This plant grows widely in southern Iran in the Hormozgan and Sistan-Baluchestan provinces where it is popularly known as garom zangi and bidam. It is also widely distributed in countries with tropical and subtropical climates (5).

TC is a tall tree (25 m in height) with horizontal branches (6). The fruit is ovoid, 5 cm in length (7), and green or red. The fruit has two winged corners, and tastes range from sweet to bitter and astringent (5). The leaves contain carbohydrates, glycosides, flavonoids, steroids, tannins, saponins, triterpenoids, and alkaloids (8).

Studies in the literature have shown that the polar extract from different parts of the plant, such as the leaves, fruits, and bark of TC have the following biological activities: antimicrobial, antifungal (9), antioxidant (10), antimetastatic (11), anti-inflammatory (12), hepatoprotective (13-15), mutagenic (16), aphrodisiac (17), and anti-diabetic (18).

2. Objectives

The present study was designed to assess the antiulcer activity of the hydroalcoholic extract of the leaves of TC.

3. Methods

3.1. Drugs and Chemicals

Indomethacin and ranitidine were purchased from the Exir Pharmaceutical Co. (Borujerd, Iran) and Chemidarou Pharmaceutical Co. (Tehran, Iran), respectively. The drugs and the hydroalcoholic extract of the TC leaves were diluted in normal saline.

3.2. Plant Material and Extract Preparation

After collecting the plants from Bandar Abbas (southern Iran), TC was identified by the agriculture research and education and natural resources center (ARENRC), Bandar Abbas, Iran (registration number 7088). In order to prepare the hydroalcoholic extract of the leaves, the leaves were powdered and 300 g of the powder was dissolved in 4,000 mL of 70% ethanol (v/v) and macerated for 72 hours. The solution was then shaken and filtered, and then vacuum evaporation was performed to remove the solvent. The semisolid extract that was obtained was oven-dried at 38°C for 72 hours (19).

3.3. Animals

Wistar rats that weighed between 200 - 250 g were provided by the animal house of Jundishapur University of Medical Sciences, Ahvaz, Iran. The rats were kept under regular 12-hour light/dark cycles at a temperature of 23 ± 2°C. Standard pellet food and tap water were available ad libitum.

3.4. Experimental Models of Gastric Ulceration in Rats

During the 48 hours before the experiment, the rats were deprived of food, but were provided with water. In order to exclude the diurnal variations in the putative regulatory factors involved in gastric functions, all experiments were conducted at the same time each day. Indomethacin (30 mg/kg) suspended in CMC (1%) was administered orally using a feeding tube (20, 21).

3.5. Experimental Groups

The present experiment compared the effects of TCLE and ranitidine, an H2 receptor blocker, on the indomethacin-induced gastric damage in rats. Six rats were allocated to 13 groups. The groups received indomethacin (30 mg/kg) orally administered plus oral TCLE (100, 200, 400, and 600 mg/kg), ranitidine (50 mg/kg) (22, 23), or normal saline (5 mL/kg).

Other groups received only TCLE (100, 200, 400, and 600 mg/kg), ranitidine (50 mg/kg), CMC (1% solution), or indomethacin.

3.6. Evaluation of Gastric Ulcers

After 5 hours, all animals were anesthetized by ether (24, 25) and sacrificed. Their stomachs and greater curvature were then dissected and rinsed with normal saline. The sum of the length (mm) of all lesions was designated as the ulcer index (UI). The mean UI and inhibition (%) were calculated using the following equations:

mean UI = sum of the total lengths of lesions in each group/number of rats in each group

3.7. Histopathological Studies

After evaluating the stomach ulcers, a longitudinal section of the anterior portion of the stomach was fixed in a 10% formalin solution for 24 hours. The fixed samples were embedded in a paraffin block, cut into 5-µm sections, placed on glass slides, and stained with hematoxylin-eosin.

3.8. Statistical Analysis

One-way analysis of variance (ANOVA) with the least significant difference (LSD) test was performed to analyze the data. Data were presented as mean ± standard deviation (SD) and P < 0.05 were considered to be significant. Statistical computations were calculated using SPSS statistics 20 for windows (SPSS Inc., Chicago, IL, USA).

4. Results

4.1. Therapeutic Effects of TCLE on Indomethacin-Induced Gastric Ulcers

Macroscopic evaluations were performed to determine the therapeutic effects of the different doses of TCLE (100, 200, 400, and 600 mg/kg) on indomethacin-induced gastric damage (Table 1). The administration of indomethacin led to very high UIs in the stomachs of the rats. While all doses of TCLE and ranitidine significantly reduced the UI in rats with indomethacin-induced gastric ulcers, the effects of TCLE (400 mg/kg) and ranitidine were not significantly different. To eliminate the effects of TCLE, ranitidine, and 1% CMC-water solution on the indomethacin ulcers, only TCLE, CMC, or ranitidine were administered to six groups; these groups did not show any damage or ulcers (Figures 1 to 3 and Table 1). Table 1 presents the protection percentage obtained by different doses of drugs.

Table 1. Effect of TCLE on Indomethacin-Induced Gastric Ulcer in Rats
GroupDose, mg/kgUlcer Index, mm2Protection (%)
TCLE + indomethacin10013.552.12
Ranitidine + indomethacin, positive control500.598
Normal saline + indomethacin, negative control26.65.67
TCLE only1000100
CMC only0100
Ranitidine only500100
Indomethacin only3028.20
Figure 1. Macroscopic View of the Treatment Groups of Indomethacin-Induced Ulcers in Rats
Macroscopic View of the Treatment Groups of Indomethacin-Induced Ulcers in Rats

Arrow shows the ulcer. A, TCLE (100 mg/kg) + indomethacin; B, TCLE (200 mg/kg) + indomethacin; C, TCLE (400 mg/kg) + indomethacin and D, TCLE (600 mg/kg) + indomethacin.

Figure 2. Macroscopic View of the Control Groups of Indomethacin-Induced Ulcers in Rats
Macroscopic View of the Control Groups of Indomethacin-Induced Ulcers in Rats

Arrow shows ulcer. A, normal saline + indomethacin and B, Ranitidine (50mg/kg) + indomethacin.

Figure 3. Macroscopic View of Indomethacin Induced Ulcer in Rat
Macroscopic View of Indomethacin Induced Ulcer in Rat

Arrow shows ulcer. A, indomethacin (30 mg/kg); B, TCLE (100 mg/kg); C, TCLE (200 mg/kg); D, TCLE (400 mg/kg); E, TCLE (600 mg/kg); F, CMC (1%); and G, Ranitidine (50 mg/kg).

4.2. Histopathology

The microscopic examination of the gastric mucosal surface cells in the indomethacin-induced groups showed some extent of necrosis, identified by highlighted cytoplasm and compressed and dingy nuclei. Some parts of the mucosal cells were separated and the glandular epithelium cells were necrotic up to the middle. The depth of the ulcers was less in the treatment groups than in the indomethacin groups. Microscopic examination showed no pathological changes in the mucosa of the six control groups. Most cases showed columnar mucosal cells with clear cytoplasm and, in some cases, capillary hyperemia (Figures 4 to 6).

Figure 4. Histopathological View of TCLE-Treatment Groups for Indomethacin-Induced Ulcers in Rats
Histopathological View of TCLE-Treatment Groups for Indomethacin-Induced Ulcers in Rats

Tthe star shows healthy mucosal cells, magnification ×100, hematoxylin and eosin staining. A, TCLE (100 mg/kg) + indomethacin shows mucosal regeneration and reduced inflammatory and ulcerous cells; B, TCLE (200 mg/kg) + indomethacin shows mucosal regeneration and reduced inflammatory and ulcerous cells; C, TCLE (400 mg/kg) + indomethacin shows mucosal regeneration and reduced inflammatory and ulcerous cells; and D, TCLE (600 mg/kg) + indomethacin shows mucosal regeneration and reduced inflammatory and ulcerous cells.

Figure 5. Histopathological View of the Control Groups for Indomethacin-Induced Ulcers in Rats
Histopathological View of the Control Groups for Indomethacin-Induced Ulcers in Rats

Magnification ×100, hematoxylin and eosin staining. A, Normal saline + indomethacin shows mucosal ulceration with inflammation (the star shows a necrotic cell); and B, Ranitidine (50 mg/kg) + indomethacin shows normal gastric mucosa with normal glands (the star shows a healthy mucosal cell).

Figure 6. Histopathological View of Indomethacin-Induced Ulcer in Rats
Histopathological View of Indomethacin-Induced Ulcer in Rats

Magnification ×100, hematoxylin and eosin staining. A, Indomethacin (30 mg/kg) shows mucosal ulceration with inflammation; B, TCLE (100 mg/kg) shows mucosal ulceration with inflammation (the star shows a necrotic cell); C, TCLE (200 mg/kg) shows normal gastric mucosa with normal glands; D, TCLE (400 mg/kg) shows normal gastric mucosa with normal glands; E, TCLE (600 mg/kg) shows normal gastric mucosa with normal glands; F, CMC (1%) shows normal gastric mucosa with normal glands; and G, Ranitidine (50 mg/kg) shows normal gastric mucosa with normal glands.

5. Discussion

Nonsteroidal anti-inflammatory drugs (NSAIDs) are believed to cause gastric ulcers by inhibiting prostaglandin synthesis and epithelial cell proliferation in the ulcer margin; epithelial cell proliferation is essential for the reepithelization of the ulcer crater (26). The role of ROS in the development of mucosal damages induced by indomethacin, ethanol, and other similar agents has also been highlighted (27). Growing attention has been paid to the use of herbal antioxidants as alternatives to synthetic agents for the effective management of drug toxicity in such cases as peptic ulcers (28).

The current study examined the effects of TCLE on the treatment of indomethacin-induced gastric ulcers in rats. Previous phytochemical studies confirmed the presence of carbohydrates, glycosides, flavonoids, steroids, tannins, saponins, triterpenoids, and alkaloid compounds in TCLE (8). Saponins, terpenoids, and flavonoids are known to possess antiulcer properties (29). According to our findings, the oral administration of TCLE could significantly reduce UI caused by indomethacin.

In a study on rats, Devi et al. (30) assessed the gastroprotective effects of the methanolic extract from Terminalia arjuna (TA) bark on gastric ulcers induced by diclofenac sodium (80 mg/kg). They measured several parameters, including lesion index, volume of gastric juice, pH, free and total acidity, pepsin concentration, and acid output in gastric juices to determine the effects of the TA extract. They also evaluated the levels of non-protein sulfhydryls, lipid peroxide, and reduced glutathione, as well as the activities of enzymatic antioxidants, such as super oxide dismutase and catalase, in the gastric mucosa. Adherent mucus content assessment and histological examinations were also performed on the stomach tissue. The researchers confirmed the gastroprotective effects of TA extract and attributed such effects to the free radical scavenging activity and cytoprotective nature of the extract.

In a study on Swiss albino rats, Gupta et al. (31) reported that the ethanol extract of Terminalia pallida Brandis (EETP) fruit had antiulcer activity against drug-, histamine-, and ethanol-induced ulcers. The researchers concluded that the extract reduced mucosal damage by increasing the antioxidant potential of the gastric mucosa.

Jawanjal et al. (32) examined the antiulcer properties of the methanolic extract of Terminalia belerica Roxb. fruit against several models of ulcers in rats. They found the extract to protect rats against aspirin-induced ulcers. However, it did not exert similar effects on cold stress restraint models of ulcer. Overall, the 70% methanolic extract of Terminalia belerica enhanced resistance to necrotizing factors, directly protected the gastric mucosa, and showed antiulcer activity.

Kumar et al. (8) performed UI evaluations and histopathological examinations to measure the protective activity of methanolic extract of TC leaves against gastric ulcers induced by pyloric ligation in rats. The researchers observed significantly lower pH, gastric volume, free and total acidity, and UI in rats treated with the extract compared with the control group. The effects of the extract were dose-dependent and no toxic effects were detected even at high doses. The researchers attributed the antiulcer activity of TC extract to its flavonoid content.

In a study on rodents, Silva et al. (33) used a variety of methods, including matrix metalloproteinase activity, microdilution, direct flow analysis-ionization electrospray ion-trap tandem mass spectrometry, and high performance liquid chromatography coupled with a photodiode array, to assess the gastroprotective and anti-Helicobacter pylori effects of the aqueous fraction (FrAq) extracted from the TC leaves. The analyses were conducted 7 and 14 days after treatment. Their findings confirmed the potent preventive and healing effects of the FrAq from TC leaves against not only acute and chronic induced gastric ulcers, but also H. pylori.

Annegowda et al. (34) evaluated the antioxidant activity of hydrolyzed extracts of TC leaves and reported a strong correlation between the phenolic content and the antioxidant activity of the extracts. They concluded that the polyphenolic content of the extracts played a major role in the antioxidant properties. According to Mininel et al. (16), punicalagin, the most abundant polyphenolic compound in the hydroalcoholic extract of TC leaves, possesses anti-inflammatory properties (35) and can decrease oxidative stress and prevent apoptosis (33).

The role of TCLE in increasing the peptic ulcer activities in rat was demonstrated in this study for the first time. Regarding the role of TCLE in the elimination of free radicals and oxidative stress, it seems that TCLE works as an antioxidant to decrease some of the indomethacin-induced gastric ulcer.




  • 1.

    Kalant H, Grant D, Mitchel J. Principles of Medical Pharmacology. 7 ed. Canada: Elsevier Canada Ltd; 2007. p. 557-9.

  • 2.

    Sostres C, Gargallo CJ, Arroyo MT, Lanas A. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2010;24(2):121-32. doi: 10.1016/j.bpg.2009.11.005. [PubMed: 20227026].

  • 3.

    Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971;231(25):232-5. [PubMed: 5284360].

  • 4.

    Verma VK, Singh N, Saxena P, Singh R. Anti-ulcer and Antioxidant activity of Moringaoleifera (Lam) leaves against Aspirin and ethanol induced gastric ulcer in rats. Int J Pharm. 2012;2(2):46-57.

  • 5.

    Thomson LAJ, Evans B. Terminalia catappa (tropical almond). Species Profiles Pacific Island Agroforestry. 2006;2:1-20.

  • 6.

    Joy PP, Thomas J, Mathew S, Skaria BP. Medicinal plants. Trop horticulture. 1998;2:449-632.

  • 7.

    Graham SA. The genera of Rhizophoraceae and Combretaceae in the southeastern United States. J Arnold Arboretum. 1964;45(3):285-301.

  • 8.

    Kumar BG, Kumari D, Sravanthi G, Rajeshwar G, Umadevi V, Kotla NG. Antiulcer activity of ethanolic extract of Terminalia catappa leaves against gastric ulcers by pyrolic ligation induced model in rats. Int J Pharm sci Sci Drug Res. 2014;6(1):38-40.

  • 9.

    Fyhrquist P, Mwasumbi L, Haeggstrom CA, Vuorela H, Hiltunen R, Vuorela P. Ethnobotanical and antimicrobial investigation on some species of Terminalia and Combretum (Combretaceae) growing in Tanzania. J Ethnopharmacol. 2002;79(2):169-77. [PubMed: 11801378].

  • 10.

    Masuda T, Yonemori S, Oyama Y, Takeda Y, Tanaka T, Andoh T, et al. Evaluation of the antioxidant activity of environmental plants: activity of the leaf extracts from seashore plants. J Agric Food Chem. 1999;47(4):1749-54. [PubMed: 10564049].

  • 11.

    Yeh CB, Yu YL, Lin CW, Chiou HL, Hsieh MJ, Yang SF. Terminalia catappa attenuates urokinase-type plasminogen activator expression through Erk pathways in Hepatocellular carcinoma. BMC Complement Altern Med. 2014;14:141. doi: 10.1186/1472-6882-14-141. [PubMed: 24886639].

  • 12.

    Fan YM, Xu LZ, Gao J, Wang Y, Tang XH, Zhao XN, et al. Phytochemical and antiinflammatory studies on Terminalia catappa. Fitoterapia. 2004;75(3-4):253-60. doi: 10.1016/j.fitote.2003.11.007. [PubMed: 15158981].

  • 13.

    Chen PS, Li JH, Liu TY, Lin TC. Folk medicine Terminalia catappa and its major tannin component, punicalagin, are effective against bleomycin-induced genotoxicity in Chinese hamster ovary cells. Cancer Lett. 2000;152(2):115-22. [PubMed: 10773401].

  • 14.

    Tang X, Gao J, Wang Y, Fan YM, Xu LZ, Zhao XN, et al. Effective protection of Terminalia catappa L. leaves from damage induced by carbon tetrachloride in liver mitochondria. J Nutr Biochem. 2006;17(3):177-82. doi: 10.1016/j.jnutbio.2005.06.008. [PubMed: 16169207].

  • 15.

    Chen PS, Li JH. Chemopreventive effect of punicalagin, a novel tannin component isolated from Terminalia catappa, on H-ras-transformed NIH3T3 cells. Toxicol Lett. 2006;163(1):44-53. doi: 10.1016/j.toxlet.2005.09.026. [PubMed: 16242868].

  • 16.

    Mininel FJ, Leonardo Junior CS, Espanha LG, Resende FA, Varanda EA, Leite CQ, et al. Characterization and Quantification of Compounds in the Hydroalcoholic Extract of the Leaves from Terminalia catappa Linn. (Combretaceae) and Their Mutagenic Activity. Evid Based Complement Alternat Med. 2014;2014:676902. doi: 10.1155/2014/676902. [PubMed: 24734110].

  • 17.

    Ratnasooriya WD, Dharmasiri MG. Effects of Terminalia catappa seeds on sexual behaviour and fertility of male rats. Asian J Androl. 2000;2(3):213-9. [PubMed: 11225980].

  • 18.

    Nagappa AN, Thakurdesai PA, Venkat Rao N, Singh J. Antidiabetic activity of Terminalia catappa Linn fruits. J Ethnopharmacol. 2003;88(1):45-50. [PubMed: 12902049].

  • 19.

    Arzi A, Ahamehe M, Sarahroodi S. Effect of hydroalcoholic extract of Lavandula officinalis on nicotine-induced convulsion in mice. Pak J Biol Sci. 2011;14(11):634-40. [PubMed: 22235504].

  • 20.

    Akpamu U, Owoyele VB, Ozor M, Osifo UC. Indomethacin-Induced Gastric Ulcer: Model in Female Wistar Rats. Int J Basic Appl Innovative Res. 2014;2(4):78-84.

  • 21.

    Yadegari M, Khazaei M, Ghorbani R, Rezae M, Izadi B, Sheikholeslam A. Wound Healing Effect of Falcaria Vulgaris’ Leaves on Aspirin Induced Gastric Ulcer in Rats [in Persian]. J Kermanshah Univ Med Sci. 2006;10(3).

  • 22.

    Dursun H, Bilici M, Albayrak F, Ozturk C, Saglam MB, Alp HH, et al. Antiulcer activity of fluvoxamine in rats and its effect on oxidant and antioxidant parameters in stomach tissue. BMC Gastroenterol. 2009;9:36. doi: 10.1186/1471-230X-9-36. [PubMed: 19457229].

  • 23.

    Olaleye SB, Farombi EO. Attenuation of indomethacin- and HCl/ethanol-induced oxidative gastric mucosa damage in rats by kolaviron, a natural biflavonoid of Garcinia kola seed. Phytother Res. 2006;20(1):14-20. doi: 10.1002/ptr.1793. [PubMed: 16397915].

  • 24.

    Boonchum W, Vacharapiyasophon P, Kanjanapothi D, Pekkoh J, Amornlerdpison D, Pumas C, et al. Anti-gastric ulcer and acute oral toxicity of aqueous extract of Turbinaria conoides from the Gulf of Thailand. Chiang Mai J Sci. 2012;39(2):292-9.

  • 25.

    Mozaffari I, Rashidi M, Taherimoghadam AR. Study of anti-inflammatory and healing effects of Achillea millefolium in the treatment of indomethacin-induced gasthic ulcer in rat [in Persian]. J Qazvin Univ Med Sci. 2005;33:9-13.

  • 26.

    Levi S, Goodlad RA, Lee CY, Stamp G, Walport MJ, Wright NA, et al. Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet. 1990;336(8719):840-3. [PubMed: 1699093].

  • 27.

    Das D, Bandyopadhyay D, Bhattacharjee M, Banerjee RK. Hydroxyl radical is the major causative factor in stress-induced gastric ulceration. Free Radic Biol Med. 1997;23(1):8-18. [PubMed: 9165292].

  • 28.

    Pratt DE. Natural Antioxidants from Plant Material. In: Huang MT, Ho CT, Le CY, editors. Phenolic Compounds in Food and Their Effects on Health II. 507. US: J Am Chem Soc; 1992. p. 54-71.

  • 29.

    Borrelli F, Izzo AA. The plant kingdom as a source of anti-ulcer remedies. Phytother Res. 2000;14(8):581-91. [PubMed: 11113992].

  • 30.

    Devi RS, Narayan S, Vani G, Shyamala Devi CS. Gastroprotective effect of Terminalia arjuna bark on diclofenac sodium induced gastric ulcer. Chem Biol Interact. 2007;167(1):71-83. doi: 10.1016/j.cbi.2007.01.011. [PubMed: 17327128].

  • 31.

    Gupta M, Mazumder UK, Manikandan L, Bhattacharya S, Senthilkumar GP, Suresh R. Anti-ulcer activity of ethanol extract of Terminaliapallida Brandis. in Swiss albino rats. J Ethnopharmacol. 2005;97(2):405-8. doi: 10.1016/j.jep.2004.10.017. [PubMed: 15707782].

  • 32.

    Jawanjal H, Rajput MS, Agrawal P, Dange V. Pharmacological evaluation of fruits of Terminalia belerica Roxb. for antiulcer activity. J Complement Integr Med. 2012;9:Article 9. doi: 10.1515/1553-3840.1556. [PubMed: 22713279].

  • 33.

    Pinheiro Silva L, Damacena de Angelis C, Bonamin F, Kushima H, Jose Mininel F, Campaner Dos Santos L, et al. Terminalia catappa L.: a medicinal plant from the Caribbean pharmacopeia with anti-Helicobacter pylori and antiulcer action in experimental rodent models. J Ethnopharmacol. 2015;159:285-95. doi: 10.1016/j.jep.2014.11.025. [PubMed: 25460589].

  • 34.

    Annegowda HV, Nee CW, Mordi MN, Ramanathan S, Mansor SM. Evaluation of Phenolic Content and Antioxidant Property of Hydrolysed Extracts of Terminalia catappa L. Leaf. Asian J Plant Sci. 2010;9(8):479-85. doi: 10.3923/ajps.2010.479.485.

  • 35.

    Lin CC, Hsu YF, Lin TC. Effects of punicalagin and punicalin on carrageenan-induced inflammation in rats. Am J Chin Med. 1999;27(3-4):371-6. doi: 10.1142/S0192415X99000422. [PubMed: 10592846].